Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary
||October 12, 2015
Note: Proceedings contain the opinion of the presenters, but do NOT reflect the conclusions of the Health and Medicine Division or the National Academies. Learn more about the differences between Reports and Proceedings.
As witnessed in the recent Ebola epidemic, our national health security increasingly depends on global health security. Yet, it can be extremely challenging to sustain public and private investment to develop medical countermeasures (MCMs) before an emerging infectious disease becomes a public health emergency in the United States and worldwide. On March 26 and 27, 2015, the Institute of Medicine (IOM) Forum on Medical and Public Health Preparedness for Catastrophic Events; Forum on Drug Discovery, Development, and Translation; and Forum on Microbial Threats co-convened a workshop in Washington, DC, to discuss how to achieve rapid and nimble MCM capability for new and emerging threats. This new workshop summary features discussions on the MCM development process in the face of three types of infectious disease outbreaks and explores the regulatory and operational challenges encountered when rapid response is needed for an already evolving worldwide emergency. Participants at the workshop also thought through potential business models for future public-private partnerships and discussed what level of sustainable funding is needed to meet the demands of emerging threats across the globe.